Mikiya Takao
Papers
1
Total Citations
3
H-Index
1
About
Mikiya Takao is a clinical researcher whose work centers on the diagnostic challenges and adverse effects of chemotherapy in colorectal cancer treatment. His primary research areas include hepatotoxicity from oxaliplatin-based regimens, the imaging pitfalls of liver metastases, and the histopathological nuances of chemotherapy-induced liver injury. Takao’s most notable contribution is a detailed case report documenting a rare instance of localized peliosis hepatis—a condition typically presenting as diffuse sinusoidal dilation—that mimicked a solitary liver metastasis during adjuvant chemotherapy. This work, cited 3 times, underscores the critical need for clinicians to consider atypical hepatic lesions when interpreting post-chemotherapy imaging, thereby preventing unnecessary surgical interventions. By highlighting the deceptive presentation of peliosis hepatis, Takao has provided a valuable cautionary insight for oncologists and radiologists managing colorectal cancer patients. His findings contribute to a deeper understanding of oxaliplatin’s vascular side effects, reinforcing the importance of histopathological confirmation in ambiguous cases. Through this focused yet impactful study, Takao has advanced the safety and precision of colorectal cancer care.
Research Focus
Key Achievements
Top Papers
- 1